vs
Kiniksa Pharmaceuticals International, plc（KNSA）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是Kiniksa Pharmaceuticals International, plc的1.1倍（$217.4M vs $202.1M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs 1.4%，领先5.6%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 0.5%），Kiniksa Pharmaceuticals International, plc自由现金流更多（$53.3M vs $36.4M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 3.0%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
KNSA vs RPD — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $217.4M |
| 净利润 | $14.2M | $3.1M |
| 毛利率 | 89.6% | 68.9% |
| 营业利润率 | 9.8% | 1.0% |
| 净利率 | 7.0% | 1.4% |
| 营收同比 | 65.0% | 0.5% |
| 净利润同比 | 259.8% | 44.1% |
| 每股收益（稀释后） | $0.18 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $202.1M | $217.4M | ||
| Q3 25 | $180.9M | $218.0M | ||
| Q2 25 | $156.8M | $214.2M | ||
| Q1 25 | $137.8M | $210.3M | ||
| Q4 24 | $122.5M | $216.3M | ||
| Q3 24 | $112.2M | $214.7M | ||
| Q2 24 | $108.6M | $208.0M | ||
| Q1 24 | $79.9M | $205.1M |
| Q4 25 | $14.2M | $3.1M | ||
| Q3 25 | $18.4M | $9.8M | ||
| Q2 25 | $17.8M | $8.3M | ||
| Q1 25 | $8.5M | $2.1M | ||
| Q4 24 | $-8.9M | $2.2M | ||
| Q3 24 | $-12.7M | $15.4M | ||
| Q2 24 | $-3.9M | $6.5M | ||
| Q1 24 | $-17.7M | $1.4M |
| Q4 25 | 89.6% | 68.9% | ||
| Q3 25 | 88.8% | 70.2% | ||
| Q2 25 | 88.1% | 70.6% | ||
| Q1 25 | 87.0% | 71.7% | ||
| Q4 24 | 85.4% | 69.5% | ||
| Q3 24 | 82.1% | 70.6% | ||
| Q2 24 | 88.7% | 70.7% | ||
| Q1 24 | 86.7% | 70.3% |
| Q4 25 | 9.8% | 1.0% | ||
| Q3 25 | 13.3% | 2.7% | ||
| Q2 25 | 12.9% | 1.6% | ||
| Q1 25 | 9.6% | -0.0% | ||
| Q4 24 | -15.7% | 3.4% | ||
| Q3 24 | -8.6% | 6.0% | ||
| Q2 24 | -0.1% | 2.5% | ||
| Q1 24 | -20.7% | 4.7% |
| Q4 25 | 7.0% | 1.4% | ||
| Q3 25 | 10.2% | 4.5% | ||
| Q2 25 | 11.4% | 3.9% | ||
| Q1 25 | 6.2% | 1.0% | ||
| Q4 24 | -7.3% | 1.0% | ||
| Q3 24 | -11.3% | 7.2% | ||
| Q2 24 | -3.6% | 3.1% | ||
| Q1 24 | -22.2% | 0.7% |
| Q4 25 | $0.18 | $0.05 | ||
| Q3 25 | $0.23 | $0.15 | ||
| Q2 25 | $0.23 | $0.13 | ||
| Q1 25 | $0.11 | $0.03 | ||
| Q4 24 | $-0.11 | $0.08 | ||
| Q3 24 | $-0.18 | $0.21 | ||
| Q2 24 | $-0.06 | $0.09 | ||
| Q1 24 | $-0.25 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $567.6M | $154.7M |
| 总资产 | $763.6M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $414.1M | $474.7M | ||
| Q3 25 | $352.1M | $407.1M | ||
| Q2 25 | $307.8M | $511.7M | ||
| Q1 25 | $268.3M | $493.5M | ||
| Q4 24 | $243.6M | $521.7M | ||
| Q3 24 | $223.8M | $443.7M | ||
| Q2 24 | $218.8M | $442.6M | ||
| Q1 24 | $213.6M | $411.7M |
| Q4 25 | $567.6M | $154.7M | ||
| Q3 25 | $535.4M | $127.2M | ||
| Q2 25 | $495.0M | $90.4M | ||
| Q1 25 | $457.5M | $52.7M | ||
| Q4 24 | $438.4M | $17.7M | ||
| Q3 24 | $437.0M | $-5.1M | ||
| Q2 24 | $435.1M | $-52.6M | ||
| Q1 24 | $431.9M | $-86.4M |
| Q4 25 | $763.6M | $1.7B | ||
| Q3 25 | $712.3M | $1.7B | ||
| Q2 25 | $661.1M | $1.6B | ||
| Q1 25 | $599.3M | $1.6B | ||
| Q4 24 | $580.6M | $1.7B | ||
| Q3 24 | $555.3M | $1.6B | ||
| Q2 24 | $542.4M | $1.5B | ||
| Q1 24 | $519.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $53.3M | $36.4M |
| 自由现金流率自由现金流/营收 | 26.4% | 16.8% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.80× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $136.4M | $146.2M |
8季度趋势，按日历期对齐
| Q4 25 | $53.9M | $37.6M | ||
| Q3 25 | $33.7M | $39.0M | ||
| Q2 25 | $28.1M | $47.5M | ||
| Q1 25 | $22.3M | $29.8M | ||
| Q4 24 | $18.8M | $63.8M | ||
| Q3 24 | $-2.2M | $44.0M | ||
| Q2 24 | $5.2M | $32.9M | ||
| Q1 24 | $4.0M | $31.1M |
| Q4 25 | $53.3M | $36.4M | ||
| Q3 25 | $33.0M | $34.8M | ||
| Q2 25 | $27.9M | $46.6M | ||
| Q1 25 | $22.2M | $28.4M | ||
| Q4 24 | $18.6M | $62.6M | ||
| Q3 24 | — | $42.6M | ||
| Q2 24 | — | $32.6M | ||
| Q1 24 | $3.9M | $30.4M |
| Q4 25 | 26.4% | 16.8% | ||
| Q3 25 | 18.2% | 16.0% | ||
| Q2 25 | 17.8% | 21.8% | ||
| Q1 25 | 16.1% | 13.5% | ||
| Q4 24 | 15.2% | 28.9% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | 4.9% | 14.8% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.4% | 1.9% | ||
| Q2 25 | 0.1% | 0.4% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | 3.80× | 12.01× | ||
| Q3 25 | 1.83× | 3.97× | ||
| Q2 25 | 1.58× | 5.70× | ||
| Q1 25 | 2.61× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KNSA
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
